Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential

Cancers(2023)10.3390/cancers16010124Source: DataRank Database

Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.71)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Lauren K. Somes ORCID,Valentina Hoyos ORCID,Diego F. Chamorro ORCID

Live enrichment

PubMed:38201551 PMC:PMC10778447 OpenAlex:https://openalex.org/W4390231129

Cancer Prevention and Research Institute of Texas (CPRIT)

Grant: RR170024

Cancer Prevention and Research Institute of Texas (CPRIT)

Grant: T2021-018

Cancer Prevention and Research Institute of Texas (CPRIT)

Grant: 993916

Cancer Prevention and Research Institute of Texas (CPRIT)

Grant: T32GM136554

National Institutes of Health

Grant: 5T32GM136554-04

The Clinical Translational Research Certificate of Added Qualification Program

FWCI

1.71

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/16/1/124/pdf?version=1703579350

publisherhttps://www.mdpi.com/2072-6694/16/1/124/pdf?version=1703579350

publisherhttps://www.mdpi.com/2072-6694/16/1/124/pdf

journalhttps://doi.org/10.3390/cancers16010124

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38201551

Fields of Study

CAR-T cell therapy researchNanowire Synthesis and ApplicationsImmunotherapy and Immune Responses0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Chimeric antigen receptorBreast cancerMedicineImmunotherapyT-cell receptorTumor microenvironmentCancer immunotherapyCancerClinical trialAdoptive cell transferT cellCancer researchImmunologyImmune systemInternal medicineClinical TrialsCar TTcr TMedical SciencesObstetrics and Gynecology610DiseasesReviewOncologyNeoplasmsMedical SpecialtiesMedicine and Health Sciences

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential

FAIR Checklist

Authors (3)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)